7 / 16
allied
academies
Page 26
Notes:
May 16-17, 2019 | Prague, Czech Republic
2
nd
International Conference on
22
nd
International Conference on
Nanomaterials and Nanotechnology
Advanced Nanoscience and Nanotechnology
Joint Event
&
Journal of Materials Science and Nanotechnology | Volume 3
Mater Sci Nanotechnol, Volume 3
Nanotech in modern vaccines
Fabio Vengoechea
1
and
Josefa Bernad-Bernad
2
1
Laboratorio Avimex SA de CV, Mexico
2
National Autonomus University of Mexico, Mexico
A
vian influenza (AI), caused by the avian influenza virus
type "A", is a disease that can affect poultry for human
consumption and some strains can cause high mortality rates
(33-100 %). In Mexico, a pandemic was registered in 2009
due to the influenza virus AH1N1. The existing vaccines (W/O
and O/W) for AI are administered repeatedly generating
deposits, fibrosis, stress, pain, among others, which leads
to lower production, lower weight and economic losses for
the producer, as well as price increase for the market. These
may contain some adjuvants that cause inflammation at
the site of application and are associated with symptoms of
apathy, lethargy and temporary lameness. In recent years,
modified-release nanotechnology systems have become
an area of global interest. A promising option is the so-
called "sensitive stimulus" polymers, which change their
structure and functions in response to external stimuli,
with which they are intended to reduce the side effects
associated with multidose therapies, so at Laboratorio
Avimex we are exploring this field to generate safe and
effective vaccines, which are projected into the future,
which is a great contribution to animal and human health.
Speaker Biography
Fabio Vengoechea is a Colombian researcher whom graduated from
the undergraduate program in Chemistry from the Quindio’s University
(Colombia, 2008). He has completed his PhD from Autonomous University
of the State of Morelos (Mexico, 2013). He has explored the synthesis
of nano and biomaterials with biocompatible catalyst organometallic
systems. He has experience in microstructural biopolymers and design of
nanopolymers, by methods such as GPC, homonuclear decoupling NMR,
TEM and SEM. He has postdoctoral studies at the Institute of Chemistry
of National Autonomus University of Mexico, where he was working
in synthesis of palladium organometallic catalyst for the production of
molecules with broad structural diversity with UGI reactions. Currently, he
is coordinator of Laboratory of Nanotechnology at Laboratorios Avimex,
where he is working in the development of modified-release vaccines
and antibiotics. He has published 8 papers in reputed journals. He likes to
combine science and sports, since he has competed as high performance
triathlete in regional teams in Colombia and Mexico.
e:
fabio.vengoechea@avimex.com.mx